Nenad lisuride transdermal patch regulatory update

Axxonis submitted an MAA to EMEA for Nenad lisuride transdermal patch to treat restless legs syndrome (RLS). Lisuride, a dopamine agonist and serotonin (5- HT2B) receptor antagonist, was originally de...